A joint venture between the Committee for the Responsible Federal Budget, Arnold Ventures, and West Health recently released a policy brief recommending policymakers consider “Equalizing Medicare Payments Regardless of Site-of-Care” to reduce health costs for households, businesses, and the federal government. In part, the authors argue: “higher payments are difficult to justify when offered to […]
It is estimated that 20–30 percent of overall health care spending may be wasteful. The Feb. 18 edition of EBRI’s Issue Brief focuses on waste related to pricing failures when it comes to lab; imaging; and special medications for conditions such as multiple sclerosis, rheumatoid arthritis, and other inflammatory disorders. Takeaways: In the aggregate, employers […]
The 2020 Community Oncology Practice Impact Report documents that 1,748 community oncology clinics and/or practices have closed, been acquired by hospitals, merged, or reported financial struggles since 2008. Data also shows 20.8% increase in practices merging with, or being acquired by, another community oncology practice and/or acquired by a corporate entity since 2018. Read the […]
Previous research demonstrates that payments from third-party payers for infused oncology medicines are higher when care is provided in hospital outpatient departments (HOPDs) compared with physician offices (POs). Some have speculated this is due to differences in patient characteristics and treatment regimens between the two sites of care. This study employed a novel analytical approach […]
In settings in which reimbursement depends on test location, higher hospital-based vs practice-based payments were associated with greater proportions of outpatient noninvasive cardiac tests performed in hospital-based locations. A recent study found that site-neutral payments may offer an incentive for testing to be performed in the more efficient location. Read the Study: Trends in Medicare […]
In a report titled, “The High Price of Hospital Care,” the Center for American Progress examines trends in hospital profits and pricing variation across geographic areas and payers. CAP offers several policy options to rein in the high cost of hospital care, including imposing site neutral payments. According to report, “hospital profitability has risen to […]
Though few patients may realize it, the cost of health care varies widely across different sites of service. A new study by the Health Care Cost Institute (HCCI) adds more evidence to the growing body of literature that shows outpatient settings cost more than office settings for performing the exact same services. In the study, […]
Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether this shift could result in increased costs for patients with three common tumor types. Read the full document: Cost Differences […]
A research letter published in JAMA Oncology examined trends in use of and spending for infused chemotherapy in the hospital outpatient department (HOPD) setting compared to the physician office setting from 2004 to 2014 among commercial insured patients. The study found the following: The rate of commercially insured patients receiving chemotherapy in HOPDs increased from […]
Read full document: Implications of Hospital Employment of Physicians on Medicare & Beneficiaries